ACT-Based Group Therapy and Mobile Application Intervention for Emotional Eating
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSaglik Bilimleri Universitesi
About this trial
This study aims to evaluate the effects of an Acceptance and Commitment Therapy (ACT)-based group therapy program, combined with an ACT-based mobile app, on emotional eating, emotion regulation, and psychological flexibility in overweight individuals. Emotional eating is a condition in which individuals frequently use eating behavior as a coping mechanism for negative emotions.
Participants will be randomly assigned to intervention groups receiving ACT-based group therapy, ACT-based group therapy combined with an ACT-based mobile app, or a control group. The intervention will last six weeks and will include structured group sessions as well as mobile-based exercises, reminders, and coping strategies.
Outcome measures will include emotional eating, emotion regulation, and psychological flexibility. Assessments will be conducted at baseline, post-intervention, and during the follow-up phase. The findings of this study are expected to contribute to the development of accessible and effective interventions for emotional eating.
Eligibility criteria
Qualifiers
Agreeing to participate in the study,
Being between 18-65 years of age,
Having a body mass index ≤ 25 (BMI ≤ 29.9),
Being able to read and write,
Disqualifiers
Having communication problems that would prevent the interview,
Having a diagnosis of a mental disorder, including an eating disorder, that would prevent participation in the study, or having concomitant serious medical conditions that could potentially jeopardize study participation.
Having undergone bariatric surgery. • Being on the waiting list for bariatric surgery.
Being pregnant, breastfeeding, or planning to become pregnant within the next 6 months.
Trial design
Treatments tested in this trial
- ACT-Based Group Therapy
- ACT-Based Mobile Application
Treatment groups
78 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov